Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam follow-up in partial onset seizures
NCT00160615Phase 3Completed
- Sponsor
- UCB
- Start
- Sep 2001
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in focal onset seizure, sponsored by UCB. Primary endpoints: Partial (Type I) Seizure Frequency Per Week at 54 months, Partial (Type IA) Seizure Frequency Per Week at 54 months and 2 more. Started Sep 2001; status: completed.
02
Drugs
levetiracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00160615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160615.